1. N-terminal pro-B-type natriuretic peptide as prognostic marker for patients of non ST-segment elevation myocardial infarction
- Author
-
Ho Sun Shon, Jong Yun Lee, Keun Ho Ryu, Kyung-Kuk Hwang, Jang Whan Bae, and Kyung Ah Kim
- Subjects
medicine.medical_specialty ,business.industry ,Metals and Alloys ,General Engineering ,medicine.disease ,medicine.anatomical_structure ,Internal medicine ,Metallic materials ,medicine ,Cardiology ,Biomarker (medicine) ,ST segment ,cardiovascular diseases ,N terminal pro b type natriuretic peptide ,Myocardial infarction ,Risk factor ,business ,Mace ,Artery - Abstract
In this work, we analyzed only the patients of the NSTEMI (non ST-segment elevation myocardial infarction) who arrived at the hospital within 12 h after symptoms started. Using NSTEMI follow-up data within, the characteristics of the clinical data, the risk factor, and the blood tested in the hospital visit were analyzed for MACE (major adverse cardiac events) patients. MACE includes cardiac death, MI (myocardial infarction), Re-PCI, and CABG (coronary artery bypass graft). As a result, from the NSTEMI patients which can be followed up for over 12 m, NT-ProBNP (p=0.014) and age (p=0.045) are found to be the independent risk factors related to MACE. Accordingly, they can be useful for the diagnosis and prognosis for NSTEMI patients as a biomarker.
- Published
- 2013